Contact – +1-276-477-5910
Email – [email protected]

Home >> Latest Reports

LATEST REPORTS

PRESS RELEASES

Global Prostate Cancer Drugs Market Research Report 2020 (Covid-19 Version)

Summary Market Segment as follows: By Region Asia-Pacific North America Europe South America Middle East & Africa By Type Hormonal Therapy Chemotherapy Immunotherapy Targeted Therapy By Application Clinics Hospitals Other By Company AbbVie As...

7/21/2020 | Drugs

Global Anti-epileptic Drugs for Pediatrics Market Research Report 2020 (Covid-19 Version)

Summary Market Segment as follows: By Region Asia-Pacific North America Europe South America Middle East & Africa By Type First Generation Second Generation Third Generation By Application Clinic Hospital Others By Company Mylan N.V. Cephalon, In...

7/21/2020 | Drugs

Global Coronary Drug-Eluting Stent Market Research Report 2020 (Covid-19 Version)

Summary Market Segment as follows: By Region Asia-Pacific North America Europe South America Middle East & Africa By Type Durable Polymer Drug-eluting Stents Bioabsorbable Polymer Drug-eluting Stent Other By Application Coronary Heart Disease Clinical By Com...

7/21/2020 | Drugs

Global Coronary Drug Market Research Report 2020 (Covid-19 Version)

Summary Market Segment as follows: By Region Asia-Pacific North America Europe South America Middle East & Africa By Type Durable Polymer Drug-eluting Stents Bioabsorbable Polymer Drug-eluting Stent Other By Application Coronary Heart Disease Clinical By Com...

7/21/2020 | Drugs

Global Multiple Sclerosis (MS) Drugs Market Research Report 2020 (Covid-19 Version)

Summary Market Segment as follows: By Region Asia-Pacific North America Europe South America Middle East & Africa By Type Copaxone (Glatiramer Acetate, Copolymer 1) Novantrone (Mitoxantrone) Gilenya (Fingolimod, Fty720) Aubagio (Teriflunomide) Tecfidera (Dim...

7/20/2020 | Drugs

Global Dystonia Drugs Market Research Report 2020 (Covid-19 Version)

Summary Market Segment as follows: By Region Asia-Pacific North America Europe South America Middle East & Africa By Type Capsules Tablets Other By Application Hospitals Clinics Other By Company Pfizer Novartis Sanofi Merck Aspen Phar...

7/20/2020 | Drugs

Global Antibody Drug Conjugate Market Research Report 2020 (Covid-19 Version)

Summary Market Segment as follows: By Region Asia-Pacific North America Europe South America Middle East & Africa By Type Adcetris Kadcyl Other By Application Hospital Pharmaceutical Company Research Institutions By Company Seattle Genetics/Takeda ...

7/20/2020 | Drugs

Global Viral Conjunctivitis Pipeline Drugs Market Research Report 2020 (Covid-19 Version)

Summary Market Segment as follows: By Region Asia-Pacific North America Europe South America Middle East & Africa By Type Acute Follicular Conjunctivitis Pipeline Drugs Subacute Or Chronic Conjunctivitis Pipeline Drugs By Application Hospitals Clinics Others...

7/20/2020 | Drugs

Weight Loss Drugs Market Research: Global Status & Forecast by Geography, Type & Application (2016-2026)

Summary According to 99Strategy, the Global Weight Loss Drugs Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during the 2021-2026. The report analyses the global Weight Loss Drugs market, the market size and growth, as well as the major market particip...

5/10/2020 | Drugs

Musculoskeletal Disorders Drugs Market Research: Global Status & Forecast by Geography, Type & Application (2016-2026)

Summary According to 99Strategy, the Global Musculoskeletal Disorders Drugs Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during the 2021-2026. The report analyses the global Musculoskeletal Disorders Drugs market, the market size and growth, as well ...

5/10/2020 | Drugs

First
Previous
3
4
5
6
7
8
9
10
11
12
Next

Summary Market Segment as follows: By Region Asia-Pacific North America Europe South America Middle East & Africa By Type Hormonal Therapy Chemotherapy Immunotherapy Targeted Therapy By Application Clinics Hospitals Other By Company AbbVie Astellas Pharma Astra Zeneca Johnson & Johnson Sanofi GlaxoSmithKline Merck Group Novartis Amgen Bayer HealthCare Ferring Pharmaceutical Janssen Pharmaceuticals Endo Pharmaceuticals BMS Takeda Pharmaceuticals Northwest Biotherapeutics Teva Pharmaceutical Boehringer Ingelheim Foresee Pharmaceuticals Tokai Pharmaceuticals Spectrum Pharmaceuticals The main contents of the report including: Section 1: Product definition, type and application, global and regional market overview; Section 2: Global and regional Market competition by company; Section 3: Global and regional sales revenue, volume and price by type; Section 4: Global and regional sales revenue, volume and price by application; Section 5: Regional export and import; Section 6: Company information, business overview, sales data and product specifications; Section 7: Industry chain and raw materials; Section 8: SWOT and Porter's Five Forces; Section 9: Conclusion. ...

7/21/2020

Summary Market Segment as follows: By Region Asia-Pacific North America Europe South America Middle East & Africa By Type First Generation Second Generation Third Generation By Application Clinic Hospital Others By Company Mylan N.V. Cephalon, Inc. GlaxoSmithKline plc Janssen Pharmaceuticals Novartis AG Pfizer, Inc. Sanofi S.A. UCB Pharma Limited Sunovion Pharmaceuticals Limited Valeant Pharmaceuticals International, Inc. Zogenix GW Pharmaceuticals Insys Zynerba The main contents of the report including: Section 1: Product definition, type and application, global and regional market overview; Section 2: Global and regional Market competition by company; Section 3: Global and regional sales revenue, volume and price by type; Section 4: Global and regional sales revenue, volume and price by application; Section 5: Regional export and import; Section 6: Company information, business overview, sales data and product specifications; Section 7: Industry chain and raw materials; Section 8: SWOT and Porter's Five Forces; Section 9: Conclusion. ...

7/21/2020

Summary Market Segment as follows: By Region Asia-Pacific North America Europe South America Middle East & Africa By Type Durable Polymer Drug-eluting Stents Bioabsorbable Polymer Drug-eluting Stent Other By Application Coronary Heart Disease Clinical By Company Boston Scientific Cordis Abbott Advantec Vascular B.Braun Melsengen AG Biosensors Biotronik Blue Medical DISA Vascular Essen Medtronic Vascular MicroPort Medical MIV Therapeutics Orbusneich Promed Medical Relisys Medical Reva Medical Sahajanand Sino Medical Sorin Terumo Medical Translumina Vascular Concepts JW Medical Systems Kinhely Lepu Medical Medfavour Medical The main contents of the report including: Section 1: Product definition, type and application, global and regional market overview; Section 2: Global and regional Market competition by company; Section 3: Global and regional sales revenue, volume and price by type; Section 4: Global and regional sales revenue, volume and price by application; Section 5: Regional export and import; Section 6: Company information, business overview, sales data and product specifications; Section 7: Industry chain and raw materials; Section 8: SWOT and Porter's Five Forces; Section 9: Conclusion. ...

7/21/2020

Summary Market Segment as follows: By Region Asia-Pacific North America Europe South America Middle East & Africa By Type Durable Polymer Drug-eluting Stents Bioabsorbable Polymer Drug-eluting Stent Other By Application Coronary Heart Disease Clinical By Company Boston Scientific Cordis Abbott Advantec Vascular B.Braun Melsengen AG Biosensors Biotronik Blue Medical DISA Vascular Essen Medtronic Vascular MicroPort Medical MIV Therapeutics Orbusneich Promed Medical Relisys Medical Reva Medical Sahajanand Sino Medical Sorin Terumo Medical Translumina Vascular Concepts JW Medical Systems Kinhely Lepu Medical Medfavour Medical The main contents of the report including: Section 1: Product definition, type and application, global and regional market overview; Section 2: Global and regional Market competition by company; Section 3: Global and regional sales revenue, volume and price by type; Section 4: Global and regional sales revenue, volume and price by application; Section 5: Regional export and import; Section 6: Company information, business overview, sales data and product specifications; Section 7: Industry chain and raw materials; Section 8: SWOT and Porter's Five Forces; Section 9: Conclusion. ...

7/21/2020

Summary Market Segment as follows: By Region Asia-Pacific North America Europe South America Middle East & Africa By Type Copaxone (Glatiramer Acetate, Copolymer 1) Novantrone (Mitoxantrone) Gilenya (Fingolimod, Fty720) Aubagio (Teriflunomide) Tecfidera (Dimethyl Fumarate) Firategrast (Sb683699, T-0047) Siponimod (Baf312) Others By Application RRMS SPMS PPMS PRMS By Company Bayer AG Bayhill Therapeutics Biogen Idec Cinnagen Daiichi Sankyo Eli Lilly Fast Forward Llc Antisense Therapeutics Apitope Five Prime Therapeutics Genmab Artielle Immunotherapeutics Genzyme Glaxosmithkline Gw Pharmaceuticals Innate Immunotherapeutics The main contents of the report including: Section 1: Product definition, type and application, global and regional market overview; Section 2: Global and regional Market competition by company; Section 3: Global and regional sales revenue, volume and price by type; Section 4: Global and regional sales revenue, volume and price by application; Section 5: Regional export and import; Section 6: Company information, business overview, sales data and product specifications; Section 7: Industry chain and raw materials; Section 8: SWOT and Porter's Five Forces; Section 9: Conclusion. ...

7/20/2020

Summary Market Segment as follows: By Region Asia-Pacific North America Europe South America Middle East & Africa By Type Capsules Tablets Other By Application Hospitals Clinics Other By Company Pfizer Novartis Sanofi Merck Aspen Pharma Shineway CSPC Harbin Pharmaceutical Group Di Ao Group The main contents of the report including: Section 1: Product definition, type and application, global and regional market overview; Section 2: Global and regional Market competition by company; Section 3: Global and regional sales revenue, volume and price by type; Section 4: Global and regional sales revenue, volume and price by application; Section 5: Regional export and import; Section 6: Company information, business overview, sales data and product specifications; Section 7: Industry chain and raw materials; Section 8: SWOT and Porter's Five Forces; Section 9: Conclusion. ...

7/20/2020

Summary Market Segment as follows: By Region Asia-Pacific North America Europe South America Middle East & Africa By Type Adcetris Kadcyl Other By Application Hospital Pharmaceutical Company Research Institutions By Company Seattle Genetics/Takeda Roche ImmunoGen Immunomedics Pfizer Celldex Therapeutics Millennium Pharmaceuticals Bayer HealthCare Mersana Therapeutics Heidelberg Pharma Oxford BioTherapeutics Takeda Pharmaceutical Company Limited The main contents of the report including: Section 1: Product definition, type and application, global and regional market overview; Section 2: Global and regional Market competition by company; Section 3: Global and regional sales revenue, volume and price by type; Section 4: Global and regional sales revenue, volume and price by application; Section 5: Regional export and import; Section 6: Company information, business overview, sales data and product specifications; Section 7: Industry chain and raw materials; Section 8: SWOT and Porter's Five Forces; Section 9: Conclusion. ...

7/20/2020

Summary Market Segment as follows: By Region Asia-Pacific North America Europe South America Middle East & Africa By Type Acute Follicular Conjunctivitis Pipeline Drugs Subacute Or Chronic Conjunctivitis Pipeline Drugs By Application Hospitals Clinics Others By Company Adenovir Pharma AB Allergan Plc NanoViricides, Inc Shire Plc NovaBay Pharmaceuticals, Inc Novartis AG Panoptes Pharma GESMBH NicOx SA The main contents of the report including: Section 1: Product definition, type and application, global and regional market overview; Section 2: Global and regional Market competition by company; Section 3: Global and regional sales revenue, volume and price by type; Section 4: Global and regional sales revenue, volume and price by application; Section 5: Regional export and import; Section 6: Company information, business overview, sales data and product specifications; Section 7: Industry chain and raw materials; Section 8: SWOT and Porter's Five Forces; Section 9: Conclusion. ...

7/20/2020

Summary According to 99Strategy, the Global Weight Loss Drugs Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during the 2021-2026. The report analyses the global Weight Loss Drugs market, the market size and growth, as well as the major market participants. The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report. Key Regions Asia Pacific North America Europe South America Middle East & Africa Key Companies Roche GSK group Teva Sandoz(Novartis) STADA-VN J.V.Co., Ltd Hexal AG National Company For Pharmaceutical Industry Lunan Pharmaceutical Group Corporation Zein Pharmaceutical Hisun Taj Pharmaceuticals Ltd Kabir Life Sciences & Research Dm Pharma China Zhongshan Pharm Key Product Type Liauid Tablets Market by Application Weight-reducing Aid Other Main Aspects covered in the Report Overview of the Weight Loss Drugs market including production, consumption, status & forecast and market growth 2016-2020 historical data and 2021-2026 market forecast Geographical analysis including major countries Overview the product type market including development Overview the end-user market including development Impact of Coronavirus on the Industry ...

5/10/2020

Summary According to 99Strategy, the Global Musculoskeletal Disorders Drugs Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during the 2021-2026. The report analyses the global Musculoskeletal Disorders Drugs market, the market size and growth, as well as the major market participants. The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report. Key Regions Asia Pacific North America Europe South America Middle East & Africa Key Companies AbbVie Amgen Johnson & Johnson F. Hoffmann-La Roche Ltd Pfizer Inc Eli Lilly Key Product Type Rheumatoid Arthritis Muscle Relaxants Others Market by Application Rheumatoid Arthritis Osteoarthritis Osteoporosis Psoriatic Arthritis Ankylosing Spondylitis Others Main Aspects covered in the Report Overview of the Musculoskeletal Disorders Drugs market including production, consumption, status & forecast and market growth 2016-2020 historical data and 2021-2026 market forecast Geographical analysis including major countries Overview the product type market including development Overview the end-user market including development Impact of Coronavirus on the Industry ...

5/10/2020

x

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT